Aurolab   Report issue

For profit
Founded: Madurai India (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2011
NCT01430923
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

latanoprost (xalatan) (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1